Set a Weekly Medication Minute Choose a specific time and day that rarely changes
The Pathway: The hypothalamus releases GHRH (stimulating) or somatostatin (inhibiting)
Luego Mounjaro, que es un medicamento diferente de una compaa diferente que en realidad no solo tiene efectos agonistas de GLP-1, sino que tambin tiene el polipptido gastrointestinal GIP, los cuales retrasan un poco el vaciado del estomago y se ha demostrado que es ms eficaz para la prdida de peso
Clinical studies have shown that tirzepatide: Significantly reduces hemoglobin A1C levels compared to placebo Promotes weight loss in a dose-dependent manner May have potential benefits for non-alcoholic fatty liver disease (NAFLD) patients Tirzepatide is typically administered as follows: Once-weekly subcutaneous injection Available in various strengths (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) Dose is usually titrated over time to reach the target dose Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Abdominal pain Tirzepatide should be used with caution in patients with: History of pancreatitis Severe gastrointestinal disease Diabetic retinopathy Pregnancy: Tirzepatide should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus
Theres no universal best medication
